Geneos Wealth Management’s PureCycle Technologies PCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.5K Hold
1,700
– – ﹤0.01% 2502
2026
Q2
$13.8K Buy
1,700
+700
+70% +$6.28K ﹤0.01% 1917
2026
Q1
$5.19K Buy
1,000
+500
+100% +$4.16K ﹤0.01% 2154
2025
Q4
$4.3K Hold
500
– – ﹤0.01% 2184
2025
Q3
$6.58K Hold
500
– – ﹤0.01% 2081
2025
Q2
$6.85K Hold
500
– – ﹤0.01% 2467
2025
Q1
$3.46K Hold
500
– – ﹤0.01% 2625
2024
Q4
$5.12K Hold
500
– – ﹤0.01% 2326
2024
Q3
$4.75K Hold
500
– – ﹤0.01% 2084
2024
Q2
$2.96K Hold
500
– – ﹤0.01% 1812
2024
Q1
$3.11K Hold
500
– – ﹤0.01% 1802
2023
Q4
$2.02K Hold
500
– – ﹤0.01% 1917
2023
Q3
$2.8K Buy
+500
New +$4.69K ﹤0.01% 1872

Other funds holding PCT

Geneos Wealth Management's PCT Position: Q3 2026 in Review

Geneos Wealth Management held its PureCycle Technologies (PCT) position steady in Q3 2026 at 1,700 shares worth $7.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2502.

Geneos Wealth Management first reported a position in PCT in Q3 2023 and has held it in 13 quarters since. The position peaked at $13.8K in Q2 2026. 171 funds tracked by Wall St. Rank hold PCT as of Q3 2026.

  • Geneos Wealth Management held 1,700 shares of PureCycle Technologies worth $7.5K as of Q3 2026.
  • Geneos Wealth Management left its PureCycle Technologies share count unchanged in Q3 2026.
  • PureCycle Technologies made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #2502 holding.
  • Geneos Wealth Management first reported a position in PureCycle Technologies in Q3 2023 and has held it in 13 quarters since.
  • Geneos Wealth Management's PureCycle Technologies position peaked at $13.8K in Q2 2026.
  • 171 funds tracked by Wall St. Rank held PureCycle Technologies as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.